Lindsay Stetson

1.2k total citations · 1 hit paper
15 papers, 621 citations indexed

About

Lindsay Stetson is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Lindsay Stetson has authored 15 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 7 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Lindsay Stetson's work include Glioma Diagnosis and Treatment (9 papers), Ferroptosis and cancer prognosis (5 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Lindsay Stetson is often cited by papers focused on Glioma Diagnosis and Treatment (9 papers), Ferroptosis and cancer prognosis (5 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Lindsay Stetson collaborates with scholars based in United States. Lindsay Stetson's co-authors include Jill S. Barnholtz‐Sloan, Quinn T. Ostrom, Haley Gittleman, Selene Virk, Yanwen Chen, Peter Liao, Taylor M. Pearl, Kristin Waite, Jean‐Eudes Dazard and Michael E. Berens and has published in prestigious journals such as PLoS ONE, Cancer Research and Molecular & Cellular Proteomics.

In The Last Decade

Lindsay Stetson

15 papers receiving 614 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidemiology of Gliomas

2014 310 citations Quinn T. Ostrom, Haley Gittleman et al. Cancer treatment and research profile →

Peers

Countries citing papers authored by Lindsay Stetson

Since Specialization

Citations

This map shows the geographic impact of Lindsay Stetson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lindsay Stetson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lindsay Stetson more than expected).

Fields of papers citing papers by Lindsay Stetson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lindsay Stetson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lindsay Stetson. The network helps show where Lindsay Stetson may publish in the future.

Co-authorship network of co-authors of Lindsay Stetson

This figure shows the co-authorship network connecting the top 25 collaborators of Lindsay Stetson. A scholar is included among the top collaborators of Lindsay Stetson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lindsay Stetson. Lindsay Stetson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Inflammatory Bowel Disease Risk Variants Are Associated with an Increased Risk of Skin Cancer 2022 ·Inflammatory Bowel Diseases ·Kelly C. Cushing, Xiaomeng Du, Yanhua Chen, Lindsay Stetson, Annapurna Kuppa, Vincent Chen, J. Michelle Kahlenberg, Jóhann E. Guðjónsson, Brett Vanderwerff, Peter Higgins, Elizabeth K. Speliotes	6
2	Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid Leukemia 2020 ·Frontiers in Oncology ·Masumi Ueda, Tammy Stefan, Lindsay Stetson, James J. Ignatz-Hoover, Benjamin Tomlinson, Richard J. Creger, Brenda Cooper, Hillard M. Lazarus, Marcos de Lima, David N. Wald, Paolo F. Caimi	9
3	Proteins inform survival-based differences in patients with glioblastoma 2020 ·Neuro-Oncology Advances ·Lindsay Stetson, Quinn T. Ostrom, Daniela Schlatzer, Peter Liao, Karen Devine, Kristin Waite, Marta Couce, Peggy L.R. Harris, Amber Kerstetter-Fogle, Michael E. Berens, Andrew E. Sloan, (unknown), (unknown), Shama P. Mirza, Mark R. Chance, Jill S. Barnholtz‐Sloan	7
4	Sexually dimorphic impact of the iron-regulating gene, HFE, on survival in glioblastoma 2020 ·Neuro-Oncology Advances ·(unknown), Vishal Midya, Brad E. Zacharia, Elizabeth A. Proctor, Sang Yong Lee, Lindsay Stetson, Justin D. Lathia, Joshua B. Rubin, Kristin Waite, Michael E. Berens, Jill S. Barnholtz‐Sloan, James R. Connor	5
5	Gliomas display distinct sex-based differential methylation patterns based on molecular subtype 2020 ·Neuro-Oncology Advances ·Mette L. Johansen, Lindsay Stetson, Vachan Vadmal, Kristin Waite, Michael E. Berens, James R. Connor, Justin D. Lathia, Joshua B. Rubin, Jill S. Barnholtz‐Sloan	21
6	Sex is an important prognostic factor for glioblastoma but not for nonglioblastoma 2019 ·Neuro-Oncology Practice ·Haley Gittleman, Quinn T. Ostrom, Lindsay Stetson, Kristin Waite, Tiffany R. Hodges, Christina Huang Wright, James Wright, Joshua B. Rubin, Michael E. Berens, Justin D. Lathia, James R. Connor, Carol Kruchko, Andrew E. Sloan, Jill S. Barnholtz‐Sloan	52
7	Models of epigenetic age capture patterns of DNA methylation in glioma associated with molecular subtype, survival, and recurrence 2018 ·Neuro-Oncology ·Peter Liao, Quinn T. Ostrom, Lindsay Stetson, Jill S. Barnholtz‐Sloan	30
8	Epidemiology of Intracranial Gliomas 2017 ·Progress in neurological surgery ·Quinn T. Ostrom, Haley Gittleman, Lindsay Stetson, Selene Virk, Jill S. Barnholtz‐Sloan	71
9	A Novel Glycogen Synthase Kinase-3 Inhibitor Optimized for Acute Myeloid Leukemia Differentiation Activity 2016 ·Molecular Cancer Therapeutics ·Sophia Hu, Masumi Ueda, Lindsay Stetson, James J. Ignatz-Hoover, Stephen Moreton, Amit Chakrabarti, Zhiqiang Xia, Goutam Karan, Marcos de Lima, Mukesh Agrawal, David N. Wald	35
10	Protein Markers Predict Survival in Glioma Patients 2016 ·Molecular & Cellular Proteomics ·Lindsay Stetson, Jean‐Eudes Dazard, Jill S. Barnholtz‐Sloan	22
11	Brain tumor biobanking in the precision medicine era: building a high-quality resource for translational research in neuro-oncology 2016 ·Neuro-Oncology Practice ·Quinn T. Ostrom, Karen Devine, Jordonna Fulop, Yingli Wolinsky, Peter Liao, Lindsay Stetson, Marta Couce, Andrew E. Sloan, Jill S. Barnholtz‐Sloan	6
12	Epidemiology of Gliomas breakdown → 2014 ·Cancer treatment and research ·Quinn T. Ostrom, Haley Gittleman, Lindsay Stetson, Selene Virk, Jill S. Barnholtz‐Sloan	310
13	Computational identification of multi-omic correlates of anticancer therapeutic response 2014 ·BMC Genomics ·Lindsay Stetson, Taylor M. Pearl, Yanwen Chen, Jill S. Barnholtz‐Sloan	32
14	Pharmacogenomic Approach to Identify Drug Sensitivity in Small-Cell Lung Cancer 2014 ·PLoS ONE ·Gary Wildey, Yanwen Chen, (unknown), Lindsay Stetson, John J. Pink, Jill S. Barnholtz‐Sloan, Afshin Dowlati	14
15	Abstract 297: Protein markers predict overall survival in glioblastoma multiforme 2014 ·Cancer Research ·Lindsay Stetson, Jill S. Barnholtz‐Sloan	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact